Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|July 22, 2020
Intracoronary Saline-Induced Hyperemia During Coronary Thermodilution Measurements of Absolute Coronary Blood Flow: An Animal Mechanistic StudyJulien Adjedj, Fabien Picard, Carlos Collet, et al.
The Journal of Invasive Cardiology|March 16, 2021
Feasibility of Quantitative Flow Ratio in Adult Patients With Anomalous Aortic Origin of the Coronary Artery With 5 Years of Clinical Follow-upJulien Adjedj, Fabien Hyafil, Farhang Aminfar, et al.
European Heart Journal|August 27, 2023
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registryAlexandre Gautier, Fabien Picard, Gregory Ducrocq, et al.
The Journal of Invasive Cardiology|October 1, 2019
Comparison of TransFemoral Transcatheter Aortic Valve Replacement Performed With a Minimally Invasive Simplified Technique: "FAST" Versus a Standard ApproachGrégoire Lefèvre, Arnaud Jégou, Grégoire Dambrin, et al.
Journal of Interventional Cardiology|August 12, 2017
Everolimus-eluting bioresorbable vascular scaffold implantation to treat saphenous vein graft disease, single-center initial experienceFabien Picard, Guillaume Marquis-Gravel, Robert Avram, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 31, 2022
Magmaris Resorbable Magnesium Scaffold Versus Conventional Drug-Eluting Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity-Score-Matching ComparisonQuentin de Hemptinne, Panagiotis Xaplanteris, Antoine Guédès, et al.
Journal of Interventional Cardiology|August 9, 2017
Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experienceFabien Picard, Robert Avram, Guillaume Marquis-Gravel, et al.
Archives of Cardiovascular Diseases|October 27, 2023
Pharmacological coronary spasm provocative testing in clinical practice: A French Coronary Atheroma and Interventional Cardiology Group (GACI) position paperFabien Picard, Julien Adjedj, Jean-Philippe Collet, et al.
Cell Reports. Medicine|September 20, 2023
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinomaBertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.
Pageof 8